PubMed:31055697
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 687-694 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T3 | 699-720 | Glycan_Motif | denotes | chondroitin-6-sulfate | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G34992DF |
| T4 | 699-710 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
| T5 | 1207-1214 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T7 | 1275-1282 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 699-720 | http://www.glycoepitope.jp/epitopes/EP0083 | denotes | chondroitin-6-sulfate |
| T2 | 699-710 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 687-694 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 687-694 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 699-720 | https://glytoucan.org/Structures/Glycans/G34992DF | denotes | chondroitin-6-sulfate |
| T4 | 699-710 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
| T5 | 1207-1214 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 1207-1214 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T7 | 1275-1282 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T8 | 1275-1282 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-98 | Sentence | denotes | A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients. |
| TextSentencer_T2 | 99-212 | Sentence | denotes | Glycosaminoglycans (GAGs) are known to play pivotal roles in physiological processes and pathological conditions. |
| TextSentencer_T3 | 213-299 | Sentence | denotes | To study interactions of GAGs with proteins, immobilization of GAGs is often required. |
| TextSentencer_T4 | 300-453 | Sentence | denotes | Current methodologies for immobilization involve modification of GAGs and/or surfaces, which can be time-consuming and may involve specialized equipment. |
| TextSentencer_T5 | 454-596 | Sentence | denotes | Here, we use an efficient and low-cost method to immobilize GAGs without any (chemical) modification using highly concentrated salt solutions. |
| TextSentencer_T6 | 597-810 | Sentence | denotes | A number of salts from the Hofmeister series were probed for their capacity to immobilize heparin and chondroitin-6-sulfate on microtiter plates applying single chain antibodies against GAGs for detection (ELISA). |
| TextSentencer_T7 | 811-953 | Sentence | denotes | From all salts tested, the cosmotropic salt ammonium sulfate was most efficient, especially at high concentrations (80-100% (v/v) saturation). |
| TextSentencer_T8 | 954-1128 | Sentence | denotes | Immobilized GAGs were bioavailable as judged by their binding of FGF2 and VEGF, and by their susceptibility towards GAG lyases (heparinase I, II and III, chondroitinase ABC). |
| TextSentencer_T9 | 1129-1312 | Sentence | denotes | Using 80% (v/v) saturated ammonium sulfate, block and continuous gradients of heparin were established and a gradient of FGF2 was created using a heparin block gradient as a template. |
| TextSentencer_T10 | 1313-1544 | Sentence | denotes | In conclusion, high concentrations of ammonium sulfate are effective for immobilization of GAGs and for the establishment of gradients of both GAGs and GAG-binding molecules, which enables the study to the biological roles of GAGs. |
| T1 | 0-98 | Sentence | denotes | A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients. |
| T2 | 99-212 | Sentence | denotes | Glycosaminoglycans (GAGs) are known to play pivotal roles in physiological processes and pathological conditions. |
| T3 | 213-299 | Sentence | denotes | To study interactions of GAGs with proteins, immobilization of GAGs is often required. |
| T4 | 300-453 | Sentence | denotes | Current methodologies for immobilization involve modification of GAGs and/or surfaces, which can be time-consuming and may involve specialized equipment. |
| T5 | 454-596 | Sentence | denotes | Here, we use an efficient and low-cost method to immobilize GAGs without any (chemical) modification using highly concentrated salt solutions. |
| T6 | 597-810 | Sentence | denotes | A number of salts from the Hofmeister series were probed for their capacity to immobilize heparin and chondroitin-6-sulfate on microtiter plates applying single chain antibodies against GAGs for detection (ELISA). |
| T7 | 811-953 | Sentence | denotes | From all salts tested, the cosmotropic salt ammonium sulfate was most efficient, especially at high concentrations (80-100% (v/v) saturation). |
| T8 | 954-1128 | Sentence | denotes | Immobilized GAGs were bioavailable as judged by their binding of FGF2 and VEGF, and by their susceptibility towards GAG lyases (heparinase I, II and III, chondroitinase ABC). |
| T9 | 1129-1312 | Sentence | denotes | Using 80% (v/v) saturated ammonium sulfate, block and continuous gradients of heparin were established and a gradient of FGF2 was created using a heparin block gradient as a template. |
| T10 | 1313-1544 | Sentence | denotes | In conclusion, high concentrations of ammonium sulfate are effective for immobilization of GAGs and for the establishment of gradients of both GAGs and GAG-binding molecules, which enables the study to the biological roles of GAGs. |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 699-720 | Glycan | denotes | chondroitin-6-sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G34992DF |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 699-720 | Glycan | denotes | chondroitin-6-sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G34992DF |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 699-720 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin-6-sulfate | http://www.glycoepitope.jp/epitopes/EP0083 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-98 | Sentence | denotes | A versatile salt-based method to immobilize glycosaminoglycans and create growth factor gradients. |
| T2 | 99-212 | Sentence | denotes | Glycosaminoglycans (GAGs) are known to play pivotal roles in physiological processes and pathological conditions. |
| T3 | 213-299 | Sentence | denotes | To study interactions of GAGs with proteins, immobilization of GAGs is often required. |
| T4 | 300-453 | Sentence | denotes | Current methodologies for immobilization involve modification of GAGs and/or surfaces, which can be time-consuming and may involve specialized equipment. |
| T5 | 454-596 | Sentence | denotes | Here, we use an efficient and low-cost method to immobilize GAGs without any (chemical) modification using highly concentrated salt solutions. |
| T6 | 597-810 | Sentence | denotes | A number of salts from the Hofmeister series were probed for their capacity to immobilize heparin and chondroitin-6-sulfate on microtiter plates applying single chain antibodies against GAGs for detection (ELISA). |
| T7 | 811-953 | Sentence | denotes | From all salts tested, the cosmotropic salt ammonium sulfate was most efficient, especially at high concentrations (80-100% (v/v) saturation). |
| T8 | 954-1128 | Sentence | denotes | Immobilized GAGs were bioavailable as judged by their binding of FGF2 and VEGF, and by their susceptibility towards GAG lyases (heparinase I, II and III, chondroitinase ABC). |
| T9 | 1129-1312 | Sentence | denotes | Using 80% (v/v) saturated ammonium sulfate, block and continuous gradients of heparin were established and a gradient of FGF2 was created using a heparin block gradient as a template. |
| T10 | 1313-1544 | Sentence | denotes | In conclusion, high concentrations of ammonium sulfate are effective for immobilization of GAGs and for the establishment of gradients of both GAGs and GAG-binding molecules, which enables the study to the biological roles of GAGs. |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 699-720 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin-6-sulfate | http://www.glycoepitope.jp/epitopes/EP0083 |